tocilizumab 与 sarilumab 治疗住院新冠成人患者的靶向试验模拟结果更正
Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland
作者更正了 Nature Communications 于 2026 年 5 月 15 日发表的文章,纠正了作者姓名的错误。该研究通过靶向试验模拟,比较了 tocilizumab 和 sarilumab 在英国和苏格兰住院新冠成人患者中的效果。
Correction to: Nature Communications https://doi.org/10.1038/s41467-026-73134-9, published online 15 May 2026
In this article the author’s name Aziz Sheikh was written as Sir Aziz Sheikh. The original article has been updated.
Author information
Author notes
These authors contributed equally: Bang Zheng, Amanj Kurdi, Alain Amstutz.
Authors and Affiliations
Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China
Bang Zheng
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China
Bang Zheng
Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
Bang Zheng, Emily Herrett, Qing Wen, Viyaasan Mahalingasivam & Laurie Tomlinson
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China
Bang Zheng
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
Amanj Kurdi
Public Health Scotland, Edinburgh, UK
Amanj Kurdi
College of Pharmacy, Hawler Medical University, Erbil, Iraq
Amanj Kurdi
Al-Kitab University, Kirkuk, Iraq
Amanj Kurdi
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Amanj Kurdi
Electronic Health Records Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Alain Amstutz
Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
Alain Amstutz
Division Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
Alain Amstutz
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Amelia Green, Rebecca Smith, Brian MacKenna, Amir Mehrkar, Seb Bacon, Ben Goldacre & Aziz Sheikh
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
John Tazare
Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK
Qing Wen
Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK
Chris Robertson
Usher Institute, University of Edinburgh, Edinburgh, UK
Aziz Sheikh
Authors
- Bang Zheng
- Amanj Kurdi
- Alain Amstutz
- Amelia Green
- Emily Herrett
- John Tazare
- Qing Wen
- Viyaasan Mahalingasivam
- Rebecca Smith
- Brian MacKenna
- Amir Mehrkar
- Seb Bacon
- Ben Goldacre
- Chris Robertson
- Aziz Sheikh
- Laurie Tomlinson
Consortia
On behalf of The OpenSAFELY Collaborative
- Bang Zheng
- , Amelia Green
- , Emily Herrett
- , John Tazare
- , Viyaasan Mahalingasivam
- , Rebecca Smith
- , Brian MacKenna
- , Amir Mehrkar
- , Seb Bacon
- , Ben Goldacre
- & Laurie Tomlinson
Corresponding authors
Correspondence to Aziz Sheikh or Laurie Tomlinson.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zheng, B., Kurdi, A., Amstutz, A. et al. Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland. Nat Commun 17, 11414 (2026). https://doi.org/10.1038/s41467-026-78874-2
Published: 04 November 2026
Version of record: 04 November 2026
DOI: https://doi.org/10.1038/s41467-026-78874-2
来源:Nature 健康护理主题 · nature.com